Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,324
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,859
Class I recallsReasonable probability of serious health consequences
24,440
Class II recallsTemporary or medically reversible health consequences
2,900
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2

Showing 4,521–4,540 of 20,511 recalls

FDA Recall United States TerminatedTerminated: June 23, 2023Historical recordClass II

Alpenland International, Inc.

Product
HEILEMANN CONFISERIE WEHNACHTSFIGUREN AUS EDELVOLLMILCH-SCHO…
Reason
The manufacturer informed the firm that they received a complaint of plastic in the product.
Published
March 8, 2023
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall TerminatedTerminated: June 14, 2024Historical recordClass II

Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01

by RISING PHARMACEUTICALS

Reason
Failed Impurities/Degradation Specifications
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

0.9% Sodium Chloride Injection, USP, 500 mL Excel Plus Container, Rx Only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-10

by B. Braun Medical Inc.

Reason
Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall CompletedHistorical recordClass II

0.9% Sodium Chloride Injection, USP, 1000 mL Excel Plus Container, Rx Only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-00

by B. Braun Medical Inc.

Reason
Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0160-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0150-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0145-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0135-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0125-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0120-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0117-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0115-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0113-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0112-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0110-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0155-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0140-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0130-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 31, 2023Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0105-5

by IBSA PHARMA INC

Reason
Subpotent Drug
Published
March 1, 2023
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited, Bachupally - 500 090, INDIA; NDC 55111-525-01.

by Dr. Reddy's Laboratories, Inc.

Reason
Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.
Published
March 1, 2023
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.